Rifampin: Difference between revisions

From IDWiki
No edit summary
No edit summary
Line 1: Line 1:
== Background ==
* Inhibits bacterial DNA-dependent RNA polymerase
* Inhibits bacterial DNA-dependent RNA polymerase
* Never given alone due to rapid resistance
* Never given alone due to rapid resistance
* Adverse effects include [[Adverse drug reaction::drug-drug interactions]], [[Adverse drug reaction::rash]], [[Adverse drug reaction::hepatitis]], [[Adverse drug reaction::influenza-like illness]], [[Adverse drug reaction::neutropenia]], and [[Adverse drug reaction::thrombocytopenia]]
* Avoid in liver failure


== Dosing ==
== Dosing ==
Line 11: Line 10:


== Safety ==
== Safety ==

* '''Avoid in liver failure'''

=== Adverse Effects ===

* Orange or red discoloration of body fluids
* [[Adverse drug reaction::drug-drug interactions|Drug-drug interactions]], [[Adverse drug reaction::rash]], [[Adverse drug reaction::hepatitis]], [[Adverse drug reaction::influenza-like illness]], [[Adverse drug reaction::neutropenia]], and [[Adverse drug reaction::thrombocytopenia]]
* Drug-drug interactions
* Flu-like syndrome<ref>Dhhar G, McColl J, Kitai I, Levy DM, Verstegen RHJ. Rifampin-induced flu-like syndrome with shock in a patient with tuberculosis infection. <abbr>''CMAJ.''</abbr> 2023;195(34):E1151-E1153. DOI: [https://doi.org/10.1503/cmaj.230317 10.1503/cmaj.230317]</ref>, a type III [[hypersensitivity reaction]] characterized by fevers, chills, myalgias, and arthalgias usually 1-4 hours (but up to 12 hours) after a dose, and lasts for 8 hours; if rechallenged, can develop hypotension and shock


=== Drug-Drug Interactions ===
=== Drug-Drug Interactions ===

Revision as of 17:29, 10 December 2023

Background

  • Inhibits bacterial DNA-dependent RNA polymerase
  • Never given alone due to rapid resistance

Dosing

  • As adjunct to fluoroquinolone for Staphylococcus aureus:
    • Weight <60 kg: 600 mg p.o. daily
    • Weight >60 kg: 450 mg p.o. twice daily

Safety

  • Avoid in liver failure

Adverse Effects

Drug-Drug Interactions

  1. Dhhar G, McColl J, Kitai I, Levy DM, Verstegen RHJ. Rifampin-induced flu-like syndrome with shock in a patient with tuberculosis infection. CMAJ. 2023;195(34):E1151-E1153. DOI: 10.1503/cmaj.230317

References

  1. ^  Gousia Dhhar, Jeanine McColl, Ian Kitai, Deborah M. Levy, Ruud H.J. Verstegen. Rifampin-induced flu-like syndrome with shock in a patient with tuberculosis infection. Canadian Medical Association Journal. 2023;195(34):E1151-E1153. doi:10.1503/cmaj.230317.